糖尿病合并高血压的降压药物选择
摘要
糖尿病患者常伴发高血压，而降压药物的选择直接关系到本病的预后。降压治疗既要使血压达标，又要注意糖脂代谢、合并症的治疗以及受损器官的保护等。本文主要从糖尿病患者合并高血压降压药物选择注意事项以及降压治疗进展等方面进行综述。
出处
《中国实用乡村医生杂志》
2013年第13期30-31,共2页
Chinese Practical Journal of Rural Doctor
二级参考文献20
-
1Uehara MH, Kohlmann NE,Zanella MT,et al. Metabolic and haemodynamic effects of metformin in patients with type 2 diabetes mellitus and hypertension. Diabetes Obes Metab, 2001,3: 319-325.
-
2Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. JAMA, 2003,289: 2560-2572.
-
3The STOP-NIDDM Trial. Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance. JAMA, 2003,290: 486-494.
-
4Pahor M. Therapeutic benefits of ACE inhibitor and other antihypertensive drugs in patients with type 2 diabetes. Diabtes Care,2000,23:888-892.
-
5Lewis EJ, Hunsicker LG, Clarke WR, et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. New Engl J Med,2001,345:851-860.
-
6Brenner BM, Cooper ME, de Zeeuw D, et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med, 2001,345: 861-869.
-
7Tuomilehto J, Rastenyte D, Birkenhagar WH, et al. For the Systolic Hypertension in Europe Trial investigators. Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension. N Engl J Med, 1999,340:677-684.
-
8ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertension patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack
-
9St John SM, Marc R, Paresh D, et al. A comparison of the effects of rosiglitazone and glyburide on cardiovascular function and glycemic control in patients with type 2 diabetes. Diabetes Care, 2002, 25: 2058-2064.
-
10Yusuf S, Sleight P, Pogue J, et al. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients: the Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med, 2000,342:145-153.
共引文献32
-
1马莉.糖尿病合并高血压51例临床治疗体会[J].医学信息（医学与计算机应用）,2014,0(11):494-494. 被引量：1
-
2张彩云.糖尿病合并高血压的治疗策略[J].实用医技杂志,2008,15(15):2003-2004. 被引量：24
-
3高九青,周娜.糖尿病肾病患者血液透析时机的选择[J].医学信息（西安上半月）,2005,18(4):392-393. 被引量：2
-
4张智灵,李志宏,陈维红.抗高血压药物的特性及其应用[J].中西医结合心脑血管病杂志,2006,4(9):793-795. 被引量：8
-
5倪长霖,张亚文,胡筱芸.2型糖尿病合并冠心病危险因素的临床研究[J].天津医药,2006,34(9):607-609. 被引量：19
-
6王连平,朱少群.糖尿病合并高血压的降压治疗[J].医药世界,2006(10):63-65. 被引量：1
-
7张平.糖尿病合并高血压降压药物选择[J].中国医药导报,2007,4(08Z):164-165. 被引量：4
-
8金世兰.高血压合并糖尿病患者的降压目标及治疗[J].医学与哲学（B）,2008,29(1):32-33. 被引量：9
-
9鲍龙伟,金世兰.高血压合并糖尿病患者的降压治疗[J].中国医药导刊,2009,11(7):1087-1088. 被引量：5
-
10杨笛.2型糖尿病合并冠状动脉粥样硬化性心脏病临床指标分析[J].浙江医学,2009,31(3):362-363.
-
1钟耀华.卡维地洛、美托洛尔治疗慢性心力衰竭临床研究[J].中国医疗前沿,2010,5(16):34-34. 被引量：10
-
2赵芳,王杰敏,杨秀花,王杰超,卢旭东,付亿玲,李静,康素娴.左旋氨氯地平及氢氯噻嗪对高血压伴舒张性心力衰竭血浆脑钠肽的影响[J].河北医药,2014,36(20):3115-3117. 被引量：2
-
3严巧莲.对比分析阵发性室上性心动过速的药物治疗[J].中国现代药物应用,2010,4(17):126-127. 被引量：2
-
4霍勇.血压之“计”在于晨[J].祝您健康,2014(2):4-5.
-
5杨玺.有哪些因素可使糖尿病患者又患高血压病[J].中国社区医师,2009,25(1):22-22. 被引量：1
-
6武金颖,潘锦峰.糖尿病患者降压药物的选择[J].实用医技杂志,1998,5(10):733-733.
-
7黄继良,谷程娟.特拉唑嗪对2型糖尿病合并高血压患者胰岛素敏感性的影响[J].辽宁药物与临床,2001,4(4):164-165.
-
8郭奕璜.胆道感染抗菌药物的选择[J].怀化医专学报,2002,1(1):100-101.
-
9段继豪,翟亚东,万会丽.依那普利联合硝苯地平缓释片治疗糖尿病合并高血压的疗效观察[J].社区医学杂志,2010,8(2):12-13. 被引量：14
-
10刘国仗.高血压病一线药物的选择[J].临床内科杂志,1993,10(6):2-4. 被引量：3
